Similar articles

• [Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].

  Bros JA, Lluís PG, Cabot GL, Pedragós AC. Bros JA, et al. Med Clin (Barc). 2011 Feb 26;136(5):207-14. doi: 10.1016/j.medcli.2009.05.022. Epub 2009 Jul 30. Med Clin (Barc). 2011. PMID: 19646718 Review. Spanish. No abstract available.
• Levothyroxine-cholestyramine interaction reemphasized.

  Harmon SM, Seifert CF. Harmon SM, et al. Ann Intern Med. 1991 Oct 15;115(8):658-9. doi: 10.7326/0003-4819-115-8-658_2. Ann Intern Med. 1991. PMID: 1892339 No abstract available.
• Conditions and drugs interfering with thyroxine absorption.

  Liwanpo L, Hershman JM. Liwanpo L, et al. Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):781-92. doi: 10.1016/j.beem.2009.06.006. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19942153 Review.
• Activated charcoal impairs propantheline absorption.

  Chaput de Saintonge DM, Herxheimer A. Chaput de Saintonge DM, et al. Eur J Clin Pharmacol. 1971 Dec;4(1):52-3. doi: 10.1007/BF00568899. Eur J Clin Pharmacol. 1971. PMID: 5151392 No abstract available.
• Cation-exchange resin and inhibition of intestinal absorption of thyroxine.

  McLean M, Kirkwood I, Epstein M, Jones B, Hall C. McLean M, et al. Lancet. 1993 May 15;341(8855):1286. doi: 10.1016/0140-6736(93)91195-r. Lancet. 1993. PMID: 8098431 No abstract available.